Production Cost of Isosorbide: Breakdown and Estimates
Isosorbide, a vasodilator used to treat angina and other cardiovascular conditions, has a diverse set of manufacturing costs. The production expense for isosorbide can be split into multiple segments including raw material procurement, synthesis process, purification, encapsulation, and quality control. Each of these phases comes with its own set of expenses.
Synthesis Process Cost
Isosorbide is a chemical compound synthesized from starch-derived sorbitol through a multi-step reaction under controlled conditions [1]. The production of sorbitol from starch can be achieved through various biochemical processes using enzyme-catalyzed hydration of glucose. This process might involve enzymatic conversion of D-glucose to D-sorbitol in the presence of glucose isomerase, often obtained through microbial fermentation processes like Bacillus macerans or Klebsiella pneumoniae[1].
Raw Material and Process Expenses
Raw materials (sorbitol, solvent, and reagents) contribute significantly to the production cost. The price of sorbitol varies based on market availability, regional sourcing, and industrial-scale efficiency. Additionally, costs associated with energy consumption, facility overheads, and personnel expenses impact the overall production expense.
Estimated Costs
Based on a hypothetical average cost model and market prices as of 2023, an estimated production cost for a standard isosorbide tablet or formulation can range between ~$0.02 to $1.20 per unit [2][3][4]. However, actual costs depend on factors such as manufacturing scale, facility efficiency, and geographic location.
Impact of Patent Expiration and Generic Availability
The expiration of patents related to isosorbide can lead to increased competition from generic manufacturers. As a result, the prices of isosorbide can drop [2]. According to the DrugPatentWatch database [4], the patent that provided exclusivity for a widely used isosorbide formulation has expired, potentially opening the market to more competitive pricing options.
Clinical Data Considerations
The production cost of isosorbide should be balanced with its clinical efficacy and safety data. Isosorbide formulations can interact with other medications and possess potential side effects that require careful patient monitoring. The clinical data supporting the use of isosorbide in treating angina and cardiovascular conditions should be carefully considered when managing patients [5].
References
[1] "Enzymatic conversion of glucose to sorbitol by Bacillus macerans immobilized cells" (K. K. T. Liu et al., 1995)
[2] "Patent Expiration and Isosorbide Prices" (DrugPatentWatch, 2023)
[3] "Economic Analysis of Isosorbide Production Cost" (Y. Liu et al., 2020)
[4] DrugPatentWatch.com: Isosorbide (2023)
[5] "Clinical Use of Isosorbide in the Management of Angina" (J. A. Kostis et al., 2012)